Multiple Myeloma and Diabetes
Joint Authors
Issa, Zeinab A.
Zantout, Mira S.
Azar, Sami T.
Source
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-11-17
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers.
It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow.
The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus.
The treatment of multiple myeloma and diabetes mellitus is multifaceted.
The coexistence of the two conditions in a patient forms a major challenge for physicians.
American Psychological Association (APA)
Issa, Zeinab A.& Zantout, Mira S.& Azar, Sami T.. 2011. Multiple Myeloma and Diabetes. ISRN Endocrinology،Vol. 2011, no. 2011, pp.1-6.
https://search.emarefa.net/detail/BIM-500270
Modern Language Association (MLA)
Issa, Zeinab A.…[et al.]. Multiple Myeloma and Diabetes. ISRN Endocrinology No. 2011 (2011), pp.1-6.
https://search.emarefa.net/detail/BIM-500270
American Medical Association (AMA)
Issa, Zeinab A.& Zantout, Mira S.& Azar, Sami T.. Multiple Myeloma and Diabetes. ISRN Endocrinology. 2011. Vol. 2011, no. 2011, pp.1-6.
https://search.emarefa.net/detail/BIM-500270
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-500270
